학술논문
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
Document Type
Article
Author
Chida, K.; Kotani, D.; Fukuoka, S.; Moriwaki, T.; Masuishi, T.; Takashima, A.; Kumekawa, Y.; Kajiwara, T.; Yamazaki, K.; Komoda, M.; Makiyama, A.; Denda, T.; Hatachi, Y.; Suto, T.; Sugimoto, N.; Enomoto, M.; Ishikawa, T.; Kashiwada, T.; Ando, K.; Yuki, S.; Okita, Y.; Kusaba, H.; Sakai, D.; Okamoto, K.; Tamura, T.; Yamashita, K.; Gosho, M.; Shimada, Y.
Source
In: Frontiers in Oncology . (Frontiers in Oncology, 8 March 2021, 11)
Subject
Language
English
ISSN
2234943X